Tag: FRESCO-2

Fruquintinib: a potential new treatment for patients with refractory mCRC

Presented By
Prof. Nageshwara Arvind Dasari, MD Anderson Cancer Centre, TX, USA
Trial
Phase 3, FRESCO-2
Conference
ESMO 2022
Type
Peer-reviewed article

16 November 2022 17:21
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com